Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Non-Current Assets: 2018-2025

Historic Non-Current Assets for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $22.8 million.

  • Verastem's Non-Current Assets rose 298.81% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year increase of 298.81%. This contributed to the annual value of $6.6 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Verastem's Non-Current Assets stood at $22.8 million, which was up 3.66% from $22.0 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's Non-Current Assets peaked at $22.8 million during Q3 2025, and registered a low of $1.7 million during Q3 2023.
  • Moreover, its 3-year median value for Non-Current Assets was $6.0 million (2024), whereas its average is $8.1 million.
  • In the last 5 years, Verastem's Non-Current Assets crashed by 89.32% in 2021 and then soared by 298.81% in 2025.
  • Over the past 5 years, Verastem's Non-Current Assets (Quarterly) stood at $2.9 million in 2021, then fell by 25.39% to $2.2 million in 2022, then declined by 28.60% to $1.7 million in 2023, then soared by 242.69% to $6.6 million in 2024, then spiked by 298.81% to $22.8 million in 2025.
  • Its Non-Current Assets stands at $22.8 million for Q3 2025, versus $22.0 million for Q2 2025 and $7.0 million for Q1 2025.